Comparison between Intravenous Sodium Valproate and Subcutaneous Sumatriptan for Treatment of Acute Migraine Attacks; Double-Blind Randomized Clinical Trial

Background: Sodium valproate (SV) has been approved for migraine prophylaxis and its intravenous form is used to treat acute migraine attacks. We compared the efficacy and safety of intravenous SV and subcutaneous Sumatriptan in managing acute migraine attacks. Methods: This double-blind randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimdel, Abolghasem, Mellat, Ali, Zeinali, Ahmad, Jafari, Elahe, Ayatollahi, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993044/
https://www.ncbi.nlm.nih.gov/pubmed/24753639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993044/
https://www.ncbi.nlm.nih.gov/pubmed/24753639

Ejemplares similares